Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases

NCT02206334 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02206334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02206334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Lead sponsor
NRG Oncology
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2014
Completion date
May 20, 2022
Enrollment
42 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

male breast carcinoma, prostate adenocarcinoma, recurrent breast carcinoma, recurrent non-small cell lung carcinoma, recurrent prostate carcinoma, stage iv breast cancer, stage iv non-small cell lung cancer, stage iv prostate cancer